BMY logo

Bristol-Myers Squibb (BMY) Free Cash Flow

BMY Annual FCF

$12.65 B
+$703.00 M+5.88%

31 December 2023

BMY Free Cash Flow Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMY Quarterly FCF

$5.27 B
+$3.20 B+155.18%

30 September 2024

BMY Quarterly FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMY TTM FCF

$13.80 B
+$858.00 M+6.63%

30 September 2024

BMY TTM FCF Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

BMY Free Cash Flow Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.9%+34.3%+9.1%
3 y3 years-4.9%+34.3%+9.1%
5 y5 years+106.9%+34.3%+9.1%

BMY Free Cash Flow High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-17.0%+5.9%at high+223.5%-9.4%+28.8%
5 y5-year-17.0%+71.6%at high+223.5%-9.4%+87.2%
alltimeall time-17.0%+5438.0%at high+506.1%-9.4%+5924.1%

Bristol-Myers Squibb Free Cash Flow History

DateAnnualQuarterlyTTM
Sept 2024
-
$5.27 B(+155.2%)
$13.80 B(+6.6%)
June 2024
-
$2.06 B(-19.1%)
$12.95 B(+3.5%)
Mar 2024
-
$2.55 B(-35.0%)
$12.51 B(-1.1%)
Dec 2023
$12.65 B(+5.9%)
$3.92 B(-11.0%)
$12.65 B(+8.2%)
Sept 2023
-
$4.41 B(+170.8%)
$11.69 B(+9.0%)
June 2023
-
$1.63 B(-39.5%)
$10.72 B(-3.3%)
Mar 2023
-
$2.69 B(-9.1%)
$11.08 B(-7.3%)
Dec 2022
$11.95 B(-21.6%)
$2.96 B(-14.0%)
$11.95 B(-6.1%)
Sept 2022
-
$3.44 B(+73.0%)
$12.72 B(-10.9%)
June 2022
-
$1.99 B(-44.1%)
$14.28 B(-5.7%)
Mar 2022
-
$3.56 B(-4.8%)
$15.14 B(-0.6%)
Dec 2021
$15.23 B(+14.5%)
$3.74 B(-25.2%)
$15.23 B(+4.6%)
Sept 2021
-
$5.00 B(+75.3%)
$14.57 B(+24.7%)
June 2021
-
$2.85 B(-21.9%)
$11.69 B(-11.5%)
Mar 2021
-
$3.65 B(+18.8%)
$13.20 B(-0.8%)
Dec 2020
$13.30 B(+80.3%)
$3.07 B(+45.3%)
$13.30 B(+9.4%)
Sept 2020
-
$2.11 B(-51.5%)
$12.16 B(-2.0%)
June 2020
-
$4.36 B(+16.3%)
$12.41 B(+24.9%)
Mar 2020
-
$3.75 B(+94.4%)
$9.94 B(+34.8%)
Dec 2019
$7.37 B(+20.6%)
$1.93 B(-18.4%)
$7.37 B(-15.3%)
Sept 2019
-
$2.37 B(+25.1%)
$8.71 B(+17.7%)
June 2019
-
$1.89 B(+59.5%)
$7.40 B(+16.2%)
Mar 2019
-
$1.19 B(-63.7%)
$6.37 B(+4.1%)
Dec 2018
$6.12 B(+44.9%)
$3.27 B(+209.5%)
$6.12 B(+64.7%)
Sept 2018
-
$1.05 B(+22.8%)
$3.71 B(-9.6%)
June 2018
-
$859.00 M(-8.2%)
$4.11 B(-10.4%)
Mar 2018
-
$936.00 M(+8.5%)
$4.59 B(+8.7%)
Dec 2017
$4.22 B(+129.0%)
$863.00 M(-40.5%)
$4.22 B(-4.7%)
Sept 2017
-
$1.45 B(+8.6%)
$4.43 B(+9.6%)
June 2017
-
$1.34 B(+134.4%)
$4.04 B(+40.2%)
Mar 2017
-
$570.00 M(-46.8%)
$2.88 B(+56.4%)
Dec 2016
$1.84 B(+43.4%)
$1.07 B(+0.8%)
$1.84 B(+34.5%)
Sept 2016
-
$1.06 B(+497.2%)
$1.37 B(+129.5%)
June 2016
-
$178.00 M(-137.9%)
$597.00 M(+83.7%)
Mar 2016
-
-$470.00 M(-178.5%)
$325.00 M(-74.7%)
Dec 2015
$1.28 B(-51.0%)
$599.00 M(+106.6%)
$1.28 B(+20.4%)
Sept 2015
-
$290.00 M(-408.5%)
$1.07 B(-32.2%)
June 2015
-
-$94.00 M(-119.2%)
$1.57 B(-39.8%)
Mar 2015
-
$490.00 M(+28.6%)
$2.61 B(-0.3%)
Dec 2014
$2.62 B(-12.8%)
$381.00 M(-52.1%)
$2.62 B(-24.0%)
Sept 2014
-
$796.00 M(-15.9%)
$3.45 B(-3.7%)
June 2014
-
$946.00 M(+89.6%)
$3.58 B(-11.5%)
Mar 2014
-
$499.00 M(-58.8%)
$4.05 B(+34.6%)
Dec 2013
$3.01 B(-52.9%)
$1.21 B(+30.2%)
$3.01 B(+22.3%)
Sept 2013
-
$929.00 M(-34.2%)
$2.46 B(-58.9%)
June 2013
-
$1.41 B(-360.0%)
$5.98 B(+7.0%)
Mar 2013
-
-$543.00 M(-182.1%)
$5.59 B(-12.6%)
Dec 2012
$6.39 B(+42.9%)
$661.00 M(-85.1%)
$6.39 B(-10.8%)
Sept 2012
-
$4.45 B(+335.6%)
$7.17 B(+65.4%)
June 2012
-
$1.02 B(+286.7%)
$4.33 B(+0.0%)
Mar 2012
-
$264.00 M(-81.6%)
$4.33 B(-3.2%)
Dec 2011
$4.47 B(+10.0%)
$1.43 B(-11.2%)
$4.47 B(-0.8%)
Sept 2011
-
$1.61 B(+58.4%)
$4.51 B(+7.6%)
June 2011
-
$1.02 B(+151.0%)
$4.19 B(+1.2%)
Mar 2011
-
$406.00 M(-72.4%)
$4.14 B(+1.7%)
Dec 2010
$4.07 B(+21.9%)
$1.47 B(+13.6%)
$4.07 B(+8.6%)
Sept 2010
-
$1.29 B(+33.7%)
$3.75 B(-0.3%)
June 2010
-
$968.00 M(+189.0%)
$3.75 B(+9.8%)
Mar 2010
-
$335.00 M(-70.8%)
$3.42 B(+2.5%)
Dec 2009
$3.33 B(+20.6%)
$1.15 B(-12.0%)
$3.33 B(+47.0%)
Sept 2009
-
$1.30 B(+106.3%)
$2.27 B(+2.2%)
June 2009
-
$632.00 M(+151.8%)
$2.22 B(-10.9%)
Mar 2009
-
$251.00 M(+209.9%)
$2.49 B(-9.9%)
Dec 2008
$2.77 B(+19.7%)
$81.00 M(-93.6%)
$2.77 B(-9.8%)
Sept 2008
-
$1.26 B(+38.9%)
$3.06 B(+32.1%)
June 2008
-
$904.00 M(+72.2%)
$2.32 B(+2.2%)
Mar 2008
-
$525.00 M(+38.2%)
$2.27 B(-1.6%)
Dec 2007
$2.31 B
$380.00 M(-25.8%)
$2.31 B(+20.6%)
Sept 2007
-
$512.00 M(-40.1%)
$1.92 B(-10.8%)
June 2007
-
$855.00 M(+51.9%)
$2.15 B(+8.9%)
DateAnnualQuarterlyTTM
Mar 2007
-
$563.00 M(-3853.3%)
$1.97 B(+52.9%)
Dec 2006
$1.29 B(+20.8%)
-$15.00 M(-102.0%)
$1.29 B(-7.8%)
Sept 2006
-
$744.00 M(+9.4%)
$1.40 B(+13.8%)
June 2006
-
$680.00 M(-671.4%)
$1.23 B(+254.2%)
Mar 2006
-
-$119.00 M(-226.6%)
$347.00 M(-67.5%)
Dec 2005
$1.07 B(-54.9%)
$94.00 M(-83.6%)
$1.07 B(-26.5%)
Sept 2005
-
$574.00 M(-384.2%)
$1.45 B(+25.6%)
June 2005
-
-$202.00 M(-133.6%)
$1.16 B(-43.5%)
Mar 2005
-
$602.00 M(+25.4%)
$2.05 B(-13.4%)
Dec 2004
$2.37 B(-6.1%)
$480.00 M(+72.7%)
$2.37 B(-15.7%)
Sept 2004
-
$278.00 M(-59.8%)
$2.81 B(-13.2%)
June 2004
-
$691.00 M(-24.7%)
$3.23 B(-7.4%)
Mar 2004
-
$918.00 M(-0.4%)
$3.49 B(+38.5%)
Dec 2003
$2.52 B(-1164.1%)
$922.00 M(+31.0%)
$2.52 B(+38.6%)
Sept 2003
-
$704.00 M(-25.8%)
$1.82 B(+0.2%)
June 2003
-
$949.00 M(-1890.6%)
$1.82 B(+80.3%)
Mar 2003
-
-$53.00 M(-124.1%)
$1.01 B(-524.9%)
Dec 2002
-$237.00 M(-105.4%)
$220.00 M(-68.6%)
-$237.00 M(-120.2%)
Sept 2002
-
$700.00 M(+400.0%)
$1.17 B(-6.2%)
June 2002
-
$140.00 M(-110.8%)
$1.25 B(-47.7%)
Mar 2002
-
-$1.30 B(-179.6%)
$2.39 B(-45.5%)
Dec 2001
$4.38 B(+7.8%)
$1.63 B(+109.8%)
$4.38 B(+1.6%)
Sept 2001
-
$777.00 M(-39.2%)
$4.31 B(-5.9%)
June 2001
-
$1.28 B(+84.1%)
$4.58 B(+10.6%)
Mar 2001
-
$694.00 M(-55.6%)
$4.14 B(+1.9%)
Dec 2000
$4.06 B(+15.6%)
$1.56 B(+48.9%)
$4.06 B(+7.0%)
Sept 2000
-
$1.05 B(+25.3%)
$3.80 B(+3.2%)
June 2000
-
$837.00 M(+36.1%)
$3.68 B(+4.2%)
Mar 2000
-
$615.00 M(-52.5%)
$3.53 B(+0.5%)
Dec 1999
$3.52 B(+17.4%)
$1.30 B(+39.1%)
$3.52 B(+14.4%)
Sept 1999
-
$932.00 M(+35.5%)
$3.07 B(-6.5%)
June 1999
-
$688.00 M(+14.9%)
$3.29 B(+14.7%)
Mar 1999
-
$599.00 M(-29.9%)
$2.87 B(-4.2%)
Dec 1998
$2.99 B(+75.2%)
$854.00 M(-25.5%)
$2.99 B(+24.5%)
Sept 1998
-
$1.15 B(+329.6%)
$2.40 B(+25.7%)
June 1998
-
$267.00 M(-63.2%)
$1.91 B(+2.4%)
Mar 1998
-
$726.00 M(+175.0%)
$1.87 B(+9.4%)
Dec 1997
$1.71 B(-16.2%)
$264.00 M(-59.8%)
$1.71 B(-9.6%)
Sept 1997
-
$656.00 M(+194.2%)
$1.89 B(+2.8%)
June 1997
-
$223.00 M(-60.6%)
$1.84 B(-12.7%)
Mar 1997
-
$566.00 M(+27.2%)
$2.11 B(+3.2%)
Dec 1996
$2.04 B(+2.7%)
$445.00 M(-26.3%)
$2.04 B(-0.8%)
Sept 1996
-
$604.00 M(+23.0%)
$2.06 B(-2.0%)
June 1996
-
$491.00 M(-1.8%)
$2.10 B(+15.0%)
Mar 1996
-
$500.00 M(+8.5%)
$1.82 B(-8.2%)
Dec 1995
$1.99 B(+14.9%)
$461.00 M(-28.5%)
$1.99 B(-0.1%)
Sept 1995
-
$645.00 M(+197.2%)
$1.99 B(+18.0%)
June 1995
-
$217.00 M(-67.3%)
$1.69 B(-6.5%)
Mar 1995
-
$663.00 M(+43.2%)
$1.80 B(+4.3%)
Dec 1994
$1.73 B(-14.0%)
$463.00 M(+35.4%)
$1.73 B(-4.8%)
Sept 1994
-
$342.00 M(+2.4%)
$1.82 B(-15.6%)
June 1994
-
$334.00 M(-43.3%)
$2.15 B(-6.1%)
Mar 1994
-
$589.00 M(+6.9%)
$2.29 B(+14.0%)
Dec 1993
$2.01 B(+45.5%)
$551.00 M(-18.7%)
$2.01 B(+4.9%)
Sept 1993
-
$678.00 M(+43.3%)
$1.92 B(+8.6%)
June 1993
-
$473.00 M(+53.6%)
$1.76 B(+24.9%)
Mar 1993
-
$308.00 M(-32.8%)
$1.41 B(+2.3%)
Dec 1992
$1.38 B(+14.4%)
$458.00 M(-12.9%)
$1.38 B(+2.1%)
Sept 1992
-
$526.00 M(+334.7%)
$1.35 B(+14.0%)
June 1992
-
$121.00 M(-56.2%)
$1.19 B(-2.6%)
Mar 1992
-
$276.00 M(-35.7%)
$1.22 B(+0.9%)
Dec 1991
$1.21 B(-2.6%)
$429.00 M(+19.2%)
$1.21 B(+4.8%)
Sept 1991
-
$360.00 M(+135.3%)
$1.15 B(+2.3%)
June 1991
-
$153.00 M(-42.3%)
$1.13 B(-8.9%)
Mar 1991
-
$265.00 M(-29.1%)
$1.24 B(-0.2%)
Dec 1990
$1.24 B(+95.1%)
$374.00 M(+12.0%)
$1.24 B(+43.2%)
Sept 1990
-
$334.00 M(+27.0%)
$865.00 M(+62.9%)
June 1990
-
$263.00 M(-1.9%)
$531.00 M(+98.1%)
Mar 1990
-
$268.00 M
$268.00 M
Dec 1989
$635.00 M
-
-

FAQ

  • What is Bristol-Myers Squibb annual free cash flow?
  • What is the all time high annual FCF for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual FCF year-on-year change?
  • What is Bristol-Myers Squibb quarterly free cash flow?
  • What is the all time high quarterly FCF for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly FCF year-on-year change?
  • What is Bristol-Myers Squibb TTM free cash flow?
  • What is the all time high TTM FCF for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb TTM FCF year-on-year change?

What is Bristol-Myers Squibb annual free cash flow?

The current annual FCF of BMY is $12.65 B

What is the all time high annual FCF for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual free cash flow is $15.23 B

What is Bristol-Myers Squibb annual FCF year-on-year change?

Over the past year, BMY annual free cash flow has changed by +$703.00 M (+5.88%)

What is Bristol-Myers Squibb quarterly free cash flow?

The current quarterly FCF of BMY is $5.27 B

What is the all time high quarterly FCF for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly free cash flow is $5.27 B

What is Bristol-Myers Squibb quarterly FCF year-on-year change?

Over the past year, BMY quarterly free cash flow has changed by +$1.34 B (+34.29%)

What is Bristol-Myers Squibb TTM free cash flow?

The current TTM FCF of BMY is $13.80 B

What is the all time high TTM FCF for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high TTM free cash flow is $15.23 B

What is Bristol-Myers Squibb TTM FCF year-on-year change?

Over the past year, BMY TTM free cash flow has changed by +$1.15 B (+9.11%)